<section class="section enhancements enhancements-metformin">
    <div class="enhancements-metformin-banner">
        <picture>
            <source srcset="../../img/metformin/enhancements-metformin.webp" type="image/webp" />
            <source srcset="../../img/metformin/enhancements-abstract.png" type="image/png" />
            <img src="../../img/metformin/enhancements-abstract.png" />
        </picture>
    </div>
    <div class="container">
        <div class="row">
            <div class="col-md-4">
                <p class="font-uppercase color-gradient section-subtitle">Enhancements</p>
                <h3 class="h3 section-title">How <i>diabetes is treated</i> today</h3>
            </div>
        </div>
        <div class="enhancements-metformin-cards">
            <div class="enhancements-metformin-card">
                <div class="enhancements-metformin-icon">
                    <img src="../img/metformin/enhancements-1.svg" alt="Metformin" />
                </div>
                <p class="enhancements-metformin-title">Metformin</p>
                <p class="enhancements-metformin-description">
                    This is the most commonly prescribed medication for <b>Type 2 diabetes</b>,
                    likely used by about <b>60-70%</b> of patients, especially as a first-line
                    treatment.
                </p>
            </div>
            <div class="enhancements-metformin-card">
                <div class="enhancements-metformin-icon">
                    <img src="../img/metformin/enhancements-2.svg" alt="Insulin" />
                </div>
                <p class="enhancements-metformin-title">Insulin</p>
                <p class="enhancements-metformin-description">
                    Used by nearly all <b>Type 1 diabetes</b> patients and many with advanced Type 2
                    diabetes, accounting for approximately <b>25-35%</b> of use.
                </p>
            </div>
            <div class="enhancements-metformin-card">
                <div class="enhancements-metformin-icon">
                    <img src="../img/metformin/enhancements-3.svg" alt="Other Oral Medications" />
                </div>
                <p class="enhancements-metformin-title">Other Oral Medications</p>
                <p class="enhancements-metformin-description">
                    <b>Sulfonylureas</b> and <b>Meglitinides</b>, once more widely used, now have a
                    smaller market share (around 5-10% and 1-3%, respectively).
                    <b>DPP-4 Inhibitors, GLP-1 Receptor Agonists</b>, and
                    <b>SGLT2 Inhibitors</b> are more recent and represent a significant portion of
                    the market, each ranging around 10-20%.
                </p>
            </div>
        </div>
    </div>
</section>
